Search

Your search keyword '"Pagani, Olivia"' showing total 494 results

Search Constraints

Start Over You searched for: Author "Pagani, Olivia" Remove constraint Author: "Pagani, Olivia"
494 results on '"Pagani, Olivia"'

Search Results

1. A Breast Cancer Smartphone App to Navigate the Breast Cancer Journey: Mixed Methods Study

2. Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland

3. Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

4. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

8. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

10. Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

11. Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.

15. Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

17. Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice

19. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland : Findings from an International Workshop

23. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

29. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

30. Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13)

31. Abstract P4-01-25: Safety analysis after 11 years of follow-up of the randomized phase III trial SAKK22/99: upfront chemotherapy in advanced HER2 positive breast cancer

32. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.

35. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

36. Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?

37. Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

40. Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

44. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer

45. The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband–Provider and Proband–Family Communication in Hereditary Breast and Ovarian Cancer

46. Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland

47. Historical early treatment effects of adjuvant endocrine therapy for breast cancer in high-risk subgroups: Reanalysis of BIG 1-98, SOFT and TEXT.

48. Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement

50. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer

Catalog

Books, media, physical & digital resources